IPP Bureau
Indian Immunologicals receive manufacturing license for Covaxin drug substance
By IPP Bureau - August 14, 2021
It falls under the Department of Biotechnology - Mission Covid Suraksha Project for augmenting manufacturing capacity for Covaxin
Novatek Pharma initiates Phase II study of oral COVID-19 drug
By IPP Bureau - August 14, 2021
This therapy may provide the first potential oral treatment for COVID-19, recognizing the global emergency of new SARS-CoV-2 variants
India observes its first `Prediabetes Day' on August 14
By IPP Bureau - August 14, 2021
Fitterfly has launched an online Prediabetes risk test which is an evidence-based, clinically validated tool for assessing an individual's risk of Prediabetes
Study shows Moderna vaccine maintains antibodies against Variants of Concern and Interest
By IPP Bureau - August 13, 2021
Studies include Alpha, Beta, Gamma, Delta, Epsilon and Iota and it maintains antibodies for six months after the second dose
Aurobindo Pharma buys Cronus Pharma Specialities for Rs 420 crores
By IPP Bureau - August 13, 2021
The acquisition will provide it with a foothold in the US $ 48 billion global animal health market
Unichem Labs receive ANDA approval for Metformin Hydrochloride
By IPP Bureau - August 13, 2021
It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Syngene sets up microbial facility as it expands biopharma-manufacturing capacity
By IPP Bureau - August 13, 2021
It strengthens Syngene’s portfolio as a fully integrated custom biomanufacturer with added mammalian and microbial capabilities for clinical and commercial supplies
USFDA grants distinct indication for Chronic Sleep Disorder
By IPP Bureau - August 13, 2021
Idiopathic hypersomnia is a life-long condition, and the approval of Xywav will be instrumental in providing treatment for symptoms such as excessive sleepiness and difficulty waking, and in effectively managing this debilitating disorder
Sun Pharma Speciality business looks encouraging: HDFC Securities
By IPP Bureau - August 13, 2021
Winlevi, the recently added anti-acne product with a new mechanism of action and broad-based use (vs Absorica), will further boost the derma portfolio and Speciality business growth
Labcorp, a leader in women’s heath solutions acquires Ovia Health
By IPP Bureau - August 13, 2021
The transaction improves patient experience, patient outcomes and aims to reduce health care costs
Wockhardt to manufacture and supply Sputnik V
By IPP Bureau - August 13, 2021
Sputnik V is a two-dose shot and has an efficacy of 91.6% against COVID 19
JB Chemicals & Pharmaceuticals PAT at Rs. 118.9 cr for Q1 FY22
By IPP Bureau - August 13, 2021
Domestic formulations business records 39 % growth while the international business revenue was largely flat as compared to Q1 FY21
Ind-Swift Laboratories PAT at Rs 18.80 cr for Q1FY22
By IPP Bureau - August 13, 2021
EPS stood at Rs 3.18
Kovai Medical Center & Hospital PAT at Rs 35.22 cr. for Q1FY22
By IPP Bureau - August 13, 2021
EPS at Rs 32.19
HCG Q1 revenue at Rs 326.58 cr. 67 per cent increase YoY
By IPP Bureau - August 13, 2021
Substantial reduction in losses
